Qube Research & Technologies (QRT)’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio OMIC Stock Details OMIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-22	Closed	-$186	–	4376
2024 Q2	$186	Sell	22 -1	-4%	-$12	﹤0.01%	3398
2024 Q1	$351	Hold	23	–	–	﹤0.01%	4106
2023 Q4	$314	Sell	23 -285	-93%	-$3.37K	﹤0.01%	3954
2023 Q3	$3.52K	Sell	308 -2,528	-89%	-$47K	﹤0.01%	3505
2023 Q2	$70.6K	Buy	+2,836	New	+$83.1K	﹤0.01%	2015
2022 Q1	–	Sell	-772	Closed	-$268K	–	3141
2021 Q4	$268K	Buy	+772	New	+$299K	﹤0.01%	1851

Other funds holding OMIC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

CRCM LP San Francisco, California $141M AUM 153.09% 1-Year Est. Return

QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s OMIC Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q3 2024, closing a stake of 22 shares — an estimated $186 sold.

Qube Research & Technologies (QRT) first reported a position in OMIC in Q4 2021 and held it in 6 quarters. The position peaked at $268K in Q4 2021. 22 funds tracked by Wall St. Rank hold OMIC as of Q3 2024.

Qube Research & Technologies (QRT) reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 22 Singular Genomics Systems, Inc. Common Stock shares in Q3 2024, an estimated $186.
Qube Research & Technologies (QRT) first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
Qube Research & Technologies (QRT)'s Singular Genomics Systems, Inc. Common Stock position peaked at $268K in Q4 2021.
22 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.